OLRATAN TRIO 40 TABLET

Product Description

OLRATAN TRIO 40 TABLET is a potent combination antihypertensive formulation expertly designed to manage high blood pressure with enhanced efficacy. This triple-action tablet combines Olmesartan Medoxomil (40 mg), an angiotensin II receptor blocker, Cilnidipine (10 mg), a calcium channel blocker, and Chlorthalidone (12.5 mg), a thiazide-like diuretic, providing comprehensive blood pressure control through multiple mechanisms.

Manufactured under stringent GMP guidelines, OLRATAN TRIO 40 is ideal for medical distributors, hospital pharmacies, and bulk buyers seeking reliable, effective antihypertensive therapy. It supports improved cardiovascular health, reduces risks of stroke, heart attack, and other complications associated with hypertension.

Key Benefits:

• Triple combination for enhanced blood pressure control

• Targets multiple pathways: vasodilation, fluid reduction, and arterial relaxation

• Improves patient adherence with once-daily dosing

• Manufactured with premium-grade ingredients ensuring safety and efficacy

Usage:

• Indicated for essential hypertension management

• Suitable for patients requiring multi-drug therapy in a simplified regimen

• Supports reduction in cardiovascular risks related to hypertension

Why Choose OLRATAN TRIO 40 TABLET?

• Clinically proven combination for superior hypertension management

• Attractive bulk purchase options for distributors and retailers

• Consistent supply and quality assurance for large-scale procurement